Jagtap A G, Shirke S S, Phadke A S
Department of Pharmacology, Bombay College of Pharmacy, Kalina, Santacruz (E), Mumbai 400 098, India.
J Ethnopharmacol. 2004 Feb;90(2-3):195-204. doi: 10.1016/j.jep.2003.09.042.
A polyherbal ayurvedic formulation from an ancient authentic classical text of ayurveda was evaluated for its activity against inflammatory bowel disease (IBD). The polyherbal formulation contained four different drugs viz., Bilwa (Aegle marmeloes), Dhanyak (Coriandrum sativum), Musta (Cyperus rotundus) and Vala (Vetiveria zinzanioids). The formulation has been tried before in clinical practice and was found to be useful in certain number of cases of IBD (ulcerative colitis), so was tried in the same form i.e., decoction (aqueous extract) in experimental animals to revalidate the claims of the same. The formulation was tried on two different experimental animal models of inflammatory bowel disease, which are acetic acid-induced colitis in mice and indomethacin-induced enterocolitis in rats. Prednisolone was used as the standard drug for comparison. The formulation showed significant inhibitory activity against inflammatory bowel disease induced in these experimental animal models. The activity was comparable with the standard drug prednisolone. The results obtained established the efficacy of this polyherbal formulation against inflammatory bowel diseases.
对一种源自阿育吠陀古老权威经典文本的多草药配方进行了抗炎症性肠病(IBD)活性评估。该多草药配方包含四种不同药物,即毕钵罗(木苹果)、达尼亚克(芫荽)、穆斯塔(香附子)和瓦拉(香根草)。该配方此前已在临床实践中试用,发现在一定数量的炎症性肠病(溃疡性结肠炎)病例中有用,因此以相同形式即汤剂(水提取物)在实验动物中进行试验,以再次验证其疗效。该配方在两种不同的炎症性肠病实验动物模型上进行了试验,分别是小鼠醋酸诱导的结肠炎和大鼠吲哚美辛诱导的小肠结肠炎。泼尼松龙用作对照的标准药物。该配方对这些实验动物模型中诱导的炎症性肠病显示出显著的抑制活性。其活性与标准药物泼尼松龙相当。所获得的结果证实了这种多草药配方对炎症性肠病的疗效。